| IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus T Rose, A Grützkau, H Hirseland, D Huscher, C Dähnrich, A Dzionek, ... Annals of the rheumatic diseases 72 (10), 1639-1645, 2013 | 151 | 2013 |
| Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study T Rose, A Grützkau, J Klotsche, P Enghard, A Flechsig, J Keller, ... Rheumatology 56 (9), 1618-1626, 2017 | 67 | 2017 |
| High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block AR Lisney, F Szelinski, K Reiter, GR Burmester, T Rose, T Dörner Annals of the rheumatic diseases 76 (8), 1476-1480, 2017 | 65 | 2017 |
| Drivers of the immunopathogenesis in systemic lupus erythematosus T Rose, T Dörner Best practice & research Clinical rheumatology 31 (3), 321-333, 2017 | 65 | 2017 |
| SIGLEC1 is a biomarker of disease activity and indicates extraglandular manifestation in primary Sjögren's syndrome T Rose, F Szelinski, A Lisney, K Reiter, SJ Fleischer, GR Burmester, ... RMD open 2 (2), e000292, 2016 | 60 | 2016 |
| Anti-dsDNA-NcX ELISA: dsDNA-loaded nucleosomes improve diagnosis and monitoring of disease activity in systemic lupus erythematosus R Biesen, C Dähnrich, A Rosemann, F Barkhudarova, T Rose, O Jakob, ... Arthritis research & therapy 13, 1-9, 2011 | 52 | 2011 |
| What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3 A Flechsig, T Rose, F Barkhudarova, R Strauss, J Klotsche, C Dähnrich, ... Clin Exp Rheumatol 35 (4), 598-606, 2017 | 44 | 2017 |
| Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility A Aue, F Szelinski, SY Weißenberg, A Wiedemann, T Rose, AC Lino, ... Rheumatology 59 (11), 3435-3442, 2020 | 32 | 2020 |
| Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options R Strauß, T Rose, SM Flint, J Klotsche, T Häupl, M Peck-Radosavljevic, ... Journal of Molecular Medicine 95, 753-765, 2017 | 27 | 2017 |
| Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F … V Jucaud, MH Ravindranath, PI Terasaki, LE Morales-Buenrostro, ... Clinical & Experimental Immunology 183 (3), 326-340, 2016 | 27 | 2016 |
| Deep phenotyping of urinary leukocytes by mass cytometry reveals a leukocyte signature for early and non-invasive prediction of response to treatment in active lupus nephritis M Bertolo, S Baumgart, P Durek, A Peddinghaus, H Mei, T Rose, ... Frontiers in immunology 11, 256, 2020 | 25 | 2020 |
| Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy RJ von Schwartzenberg, U Elbelt, M Ventz, K Mai, T Kienitz, L Maurer, ... Endocrinology, Diabetes & Metabolism Case Reports 2015 (1), 2015 | 24 | 2015 |
| Observational study and brief analysis of diagnostic criteria in relapsing polychondritis T Rose, U Schneider, M Bertolo, J Klotsche, V Casteleyn, R Biesen, ... Rheumatology International 38, 2095-2101, 2018 | 23 | 2018 |
| Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE R Biesen, T Rose, BF Hoyer, T Alexander, F Hiepe Lupus 25 (8), 823-829, 2016 | 23 | 2016 |
| Procalcitonin exerts a mediator role in septic shock through the calcitonin gene-related peptide receptor A Baranowsky, J Appelt, C Kleber, T Lange, P Ludewig, D Jahn, ... Critical Care Medicine 49 (1), e41-e52, 2021 | 22 | 2021 |
| SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies M Graf, SL von Stuckrad, A Uruha, J Klotsche, L Zorn-Pauly, ... RMD open 8 (1), e001934, 2022 | 21 | 2022 |
| Osmium-labeled microspheres for bead-based assays in mass cytometry L Budzinski, AR Schulz, S Baumgart, T Burns, T Rose, H Hirseland, ... The Journal of Immunology 202 (10), 3103-3112, 2019 | 21 | 2019 |
| Macrophage activation syndrome in a patient with adult-onset Still’s disease following first COVID-19 vaccination with BNT162b2 F Muench, M Krusche, LE Sander, T Rose, GR Burmester, U Schneider BMC rheumatology 5, 1-4, 2021 | 16 | 2021 |
| Circulating pentraxin3-specific b cells are decreased in lupus nephritis M Gatto, A Wiedemann, N Nomovi, K Reiter, E Schrezenmeier, T Rose, ... Frontiers in immunology 10, 29, 2019 | 15 | 2019 |
| SIGLEC-1 in systemic sclerosis: A useful biomarker for differential diagnosis J Höppner, V Casteleyn, R Biesen, T Rose, W Windisch, GR Burmester, ... Pharmaceuticals 15 (10), 1198, 2022 | 12 | 2022 |
Falk HiepeCharité - Universitätsmedizin Berlin & Deutsches RheumaForschungszentrum Berlin在 charite.de 的电子邮件经过验证
